Head and Neck TumorsHead and Neck TumorsОпухоли головы и шеи2222-14682411-4634Publishing House ABV Press18310.17650/2222-1468-2015-5-4-41-47LITERATURE REVIEWОБЗОР ЛИТЕРАТУРЫBrachytherapy in thetreatment of the oral and oropharyngeal cancerБрахитерапия злокачественных опухолей полости рта и ротоглоткиZhumankulovA. M.ЖуманкуловА. М.
Russian Federation

6 / 8 L. Tolstoy St., Saint-Petersburg, 197022;

56 Veteranov Prospekt, Saint-Petersburg, 198255

197022, Санкт-Петербург, ул. Л. Толстого, 6 / 8;

198255, Санкт-Петербург, проспект Ветеранов, 56

OstrinskayaT. V.ОстринскаяТ. В.
Russian Federation

56 Veteranov Prospekt, Saint-Petersburg, 198255

198255, Санкт-Петербург, проспект Ветеранов, 56

tatyanaostrinskaya@yandex.ruLitvinovA. P.ЛитвиновА. П.
Russian Federation

6 / 8 L. Tolstoy St., Saint-Petersburg, 197022

197022, Санкт-Петербург, ул. Л. Толстого, 6 / 8

LebedevaZ. S.ЛебедеваЖ. С.
Russian Federation

6 / 8 L. Tolstoy St., Saint-Petersburg, 197022

197022, Санкт-Петербург, ул. Л. Толстого, 6 / 8

Pavlov First Saint-Petersburg State Medical UniversityГБОУ ВПО «Первый Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова»Saint-Petersburg City Clinical Oncology DispensaryСПб ГБУЗ «Городской клинический онкологический диспансер»301220155441471601201616012016Copyright ©; 2015, Zhumankulov A.M., Ostrinskaya T.V., Litvinov A.P., Lebedeva Z.S.Copyright ©; 2015, Жуманкулов А.М., Остринская Т.В., Литвинов А.П., Лебедева Ж.С.2015Zhumankulov A.M., Ostrinskaya T.V., Litvinov A.P., Lebedeva Z.S.Жуманкулов А.М., Остринская Т.В., Литвинов А.П., Лебедева Ж.С.https://creativecommons.org/licenses/by/4.0https://ogsh.abvpress.ru/jour/article/view/183

Background. One of the methods of radiotherapy of malignant tumors of oral cavity and oropharyngeal region today is interstitial radiation therapy – brachytherapy, allowing you to create the optimum dose of irradiation to the tumor, necessary for its destruction, without severe radiation reactions in the surrounding tissues unchanged. Brachytherapy has the following advantages: high precision – the ability of the local summarization of high single doses in a limited volume of tissue; good tolerability; a short time of treatment. At this time, brachytherapy is the method of choice used as palliative therapy and as a component of radical treatment.

Objective: The purpose of this article is a literature review about the latest achievements of interstitial brachytherapy in malignant tumors of the oral cavity and oropharynx.

Введение. Одним из методов лучевой терапии злокачественных опухолей полости рта и орофарингеальной области на сегодняшний день является внутритканевая лучевая терапия – брахитерапия, позволяющая создавать оптимальные дозы облучения в очаге опухоли, необходимые для ее разрушения, без тяжелых лучевых реакций в окружающих неизмененных тканях. Брахитерапия имеет следующие преимущества: высокая прецизионность – возможность локального подведения высоких разовых доз в ограниченном объеме ткани, хорошая переносимость, короткий период лечения. На данное время брахитерапия применяется в качестве паллиативной терапии, а также как компонент радикального лечения.

Целью данной статьи является обзор литературы о современных достижениях внутритканевой брахитерапии при злокачественных опухолях полости рта и ротоглотки.

malignant tumors of the oral cavity and oropharynxinterstitial brachytherapycombined radiation therapychemoradiotherapyзлокачественные опухоли полости рта и ротоглоткивнутритканевая брахитерапиясочетанная лучевая терапияхимиолучевая терапия1. Пачес А.И. Опухоли головы и шеи. М.: Медицина, 1983. 416 с. [Paches А.I. Head and neck tumors. Мoscow: Меditsina, 1983. 416 p. (In Russ.)].Пачес А.И. Опухоли головы и шеи. М.: Медицина, 1983. 416 с. [Paches А.I. Head and neck tumors. Мoscow: Меditsina, 1983. 416 p. (In Russ.)].2. Любаев В.Л. Хирургический метод в лечении местно-распространенного рака слизистой оболочки полости рта и ротоглотки. Дис. … докт. мед. наук. М., 1985. 324 с. [Lubaev V.L. Surgical method in the treatment of the locally spread cancer of the mucous membrane of the mouth and nasopharynx. Thesis … of doctor of medical sciences. Мoscow, 1985. 324 p. (In Russ.)].Любаев В.Л. Хирургический метод в лечении местно-распространенного рака слизистой оболочки полости рта и ротоглотки. Дис. … докт. мед. наук. М., 1985. 324 с. [Lubaev V.L. Surgical method in the treatment of the locally spread cancer of the mucous membrane of the mouth and nasopharynx. Thesis … of doctor of medical sciences. Мoscow, 1985. 324 p. (In Russ.)].3. Vokes E.E., Kies M.S., Haraf D.J. et al. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head neck cancer. J Clin Oncol 2000;18(8): 1652–61.Vokes E.E., Kies M.S., Haraf D.J. et al. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head neck cancer. J Clin Oncol 2000;18(8): 1652–61.4. Sanderson R.J., Ironside J.A. Squamous cell carcinomas of the head and neck. BMJ 2002;325(7368):822–7.Sanderson R.J., Ironside J.A. Squamous cell carcinomas of the head and neck. BMJ 2002;325(7368):822–7.5. Чиссов В.И., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2010 году. М., 2011. 188 с. [Chissov V.I., Starinsky V.V., Petrova G.V. Status of the oncologic assistance to the population of Russia in 2010. Мoscow, 2011. 188 p. (In Russ.)].Чиссов В.И., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2010 году. М., 2011. 188 с. [Chissov V.I., Starinsky V.V., Petrova G.V. Status of the oncologic assistance to the population of Russia in 2010. Мoscow, 2011. 188 p. (In Russ.)].6. Барышев В.В., Андреев В.Г., Панкратов В.А. и др. Сравнительная характеристика методик лечения больных раком гортани Т3N1–3M0 при проведении самостоятельного лучевого и комбинированного лечения. Сибирский онкологический журнал 2006;1(17):9–13. [Baryshev V.V., Аndreev V.G., Pankratov V.А. et al. Сomparative characteristics of methods of treatment of patients with Т3N1–3M0 larynx cancer at the independent radial and combined treatment. Sibirskiy onkologicheskiy zhurnal = Siberian Oncologic Magazine 2006;1(17):9–13. (In Russ.)].Барышев В.В., Андреев В.Г., Панкратов В.А. и др. Сравнительная характеристика методик лечения больных раком гортани Т3N1–3M0 при проведении самостоятельного лучевого и комбинированного лечения. Сибирский онкологический журнал 2006;1(17):9–13. [Baryshev V.V., Аndreev V.G., Pankratov V.А. et al. Сomparative characteristics of methods of treatment of patients with Т3N1–3M0 larynx cancer at the independent radial and combined treatment. Sibirskiy onkologicheskiy zhurnal = Siberian Oncologic Magazine 2006;1(17):9–13. (In Russ.)].7. Красноперова Л.Д., Муфазалов Ф.Ф., Сакаева Д.Д. и др. Методика химиолучевого лечения местно-распространенного плоскоклеточного рака головы и шеи. Методические рекомендации МЗ РБ. Уфа, 2007. 24 с. [Krasnoperova L.D., Мufazalov F.F., Sakaeva D.D. et al. Меthods of the chemical & radial treatment of the locally spread squamous head and neck cancer. Меthodic recommendations of the Healthcare Ministry of the Republic of Bashkiria. Ufa, 2007. 24 p. (In Russ.)].Красноперова Л.Д., Муфазалов Ф.Ф., Сакаева Д.Д. и др. Методика химиолучевого лечения местно-распространенного плоскоклеточного рака головы и шеи. Методические рекомендации МЗ РБ. Уфа, 2007. 24 с. [Krasnoperova L.D., Мufazalov F.F., Sakaeva D.D. et al. Меthods of the chemical & radial treatment of the locally spread squamous head and neck cancer. Меthodic recommendations of the Healthcare Ministry of the Republic of Bashkiria. Ufa, 2007. 24 p. (In Russ.)].8. Павлов А.С. Внутритканевая гамма- и бетатерапия злокачественных опухолей. М.: Медицина, 1967. [Pavlov А.S. Inter-tissue gamma- and betatherapy of malignant tumors. Мoscow: Меditsina, 1967. (In Russ.)].Павлов А.С. Внутритканевая гамма- и бетатерапия злокачественных опухолей. М.: Медицина, 1967. [Pavlov А.S. Inter-tissue gamma- and betatherapy of malignant tumors. Мoscow: Меditsina, 1967. (In Russ.)].9. Henschke U.K., Hilaris B.S., Mahan G.D. Afterloading in interstitial and intracavitary radiation therapy. Am J Roentgenol Radium Ther Nucl Med 1963;90:386–95.Henschke U.K., Hilaris B.S., Mahan G.D. Afterloading in interstitial and intracavitary radiation therapy. Am J Roentgenol Radium Ther Nucl Med 1963;90:386–95.10. Kakimoto N., Inoue T., Inoue T. et al. High-dose-rate interstitial brachytherapy for mobile tongue cancer: influence of thenon-irradiated period. Anticancer Res 2006;26(5B):3933–7.Kakimoto N., Inoue T., Inoue T. et al. High-dose-rate interstitial brachytherapy for mobile tongue cancer: influence of thenon-irradiated period. Anticancer Res 2006;26(5B):3933–7.11. Kakimoto N., Inoue T., Inoue T. et al. Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer. Radiother Oncol 2003;68(2):123–8.Kakimoto N., Inoue T., Inoue T. et al. Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer. Radiother Oncol 2003;68(2):123–8.12. Fijuth J. Is there any place for LDR brachytherapy for headand neck carcinomas in HDR era? J Contemp Brachyther 2009;1(1):62–6.Fijuth J. Is there any place for LDR brachytherapy for headand neck carcinomas in HDR era? J Contemp Brachyther 2009;1(1):62–6.13. Lefebvre J.L., Coche-Dequeant B., Buisset E. et al. Management of early oral cavity cancer. Experience of Centre Oscar Lambret. Eur J Cancer B Oral Oncol 1994;303B:216–20.Lefebvre J.L., Coche-Dequeant B., Buisset E. et al. Management of early oral cavity cancer. Experience of Centre Oscar Lambret. Eur J Cancer B Oral Oncol 1994;303B:216–20.14. Mazeron R. Brachytherapy in head and neck cancers. Techniques. Athens, 2013.Mazeron R. Brachytherapy in head and neck cancers. Techniques. Athens, 2013.15. Mazeron J.J., Ardietb J.M., Haie-Méder C. GEC-ESTRO recommendations for brachytherapy for head and neck squamouscell carcinomas. Radiother Oncol 2009;91(2):150–6.Mazeron J.J., Ardietb J.M., Haie-Méder C. GEC-ESTRO recommendations for brachytherapy for head and neck squamouscell carcinomas. Radiother Oncol 2009;91(2):150–6.16. Pernot M., Malissard L., Aletti P. et al. Iridium-192 brachytherapy in the management of 147 T2N0 oral tongue carcinomas treated with radiation alone: comparison of two treatment techniques. Radiother Oncol 1992;23(4):223–8.Pernot M., Malissard L., Aletti P. et al. Iridium-192 brachytherapy in the management of 147 T2N0 oral tongue carcinomas treated with radiation alone: comparison of two treatment techniques. Radiother Oncol 1992;23(4):223–8.17. Pernot M., Malissard L., Hoffstetter S. The study of tumoral, radiobiological and general health factors that influence results and complications in a series of 448 oral tongue carcinomas treated exclusively by irradiation. Int J Radiat Oncol Biol Phys 1994;29(4):673–9.Pernot M., Malissard L., Hoffstetter S. The study of tumoral, radiobiological and general health factors that influence results and complications in a series of 448 oral tongue carcinomas treated exclusively by irradiation. Int J Radiat Oncol Biol Phys 1994;29(4):673–9.18. Pernot M., Aletti J.M., Carolus J. et al. Indications, techniques and results of postoperative brachytherapy in head and neck cancer of the oral cavity. Radiother Oncol 1995;35(3):186–92.Pernot M., Aletti J.M., Carolus J. et al. Indications, techniques and results of postoperative brachytherapy in head and neck cancer of the oral cavity. Radiother Oncol 1995;35(3):186–92.19. Puthawala A.A., Syed A.M., Eads D.L. et al. Limited external beam and interstitial 192iridium irradiation in the treatment of carcinoma of the base of the tongue: a ten year experience. Int J Radiat Oncol Biol Phys 1988;14(5):839–48.Puthawala A.A., Syed A.M., Eads D.L. et al. Limited external beam and interstitial 192iridium irradiation in the treatment of carcinoma of the base of the tongue: a ten year experience. Int J Radiat Oncol Biol Phys 1988;14(5):839–48.20. Mohanti B.K., Bansal M., Bahadur S. et al. Interstitial brachytherapy with or without external beam irradiation in head and neck cancer: Institute Rotary Cancer Hospital experience. Clin Oncol (R Coll Radiol) 2001;13(5):345–52.Mohanti B.K., Bansal M., Bahadur S. et al. Interstitial brachytherapy with or without external beam irradiation in head and neck cancer: Institute Rotary Cancer Hospital experience. Clin Oncol (R Coll Radiol) 2001;13(5):345–52.21. Nose T., Koizumi M., Nishiyama K. Highdose-rate interstitial brachytherapy for oropharyngeal carcinoma: results of 83 lesions in 82 patients. Int J Radiat Oncol Biol Phys 2004;59(4):983–91.Nose T., Koizumi M., Nishiyama K. Highdose-rate interstitial brachytherapy for oropharyngeal carcinoma: results of 83 lesions in 82 patients. Int J Radiat Oncol Biol Phys 2004;59(4):983–91.22. Takácsi-Nagy Z., ObernaF., Koltai P. et al. Long-term outcomes with high-dose-rate brachytherapy for the management of base of tongue cancer. Brachytherapy, 2013;12(6):535–41.Takácsi-Nagy Z., ObernaF., Koltai P. et al. Long-term outcomes with high-dose-rate brachytherapy for the management of base of tongue cancer. Brachytherapy, 2013;12(6):535–41.23. Chen J., Pappas L., Moeller J.H. et al. Treatment of oropharyngeal squamous cell carcinoma with external beam radiation combined with interstitial brachytherapy. Head Neck 2007;29(4):362–9.Chen J., Pappas L., Moeller J.H. et al. Treatment of oropharyngeal squamous cell carcinoma with external beam radiation combined with interstitial brachytherapy. Head Neck 2007;29(4):362–9.24. Do L., Puthawala A., Syed N. et al. Interstitial brachytherapy as boost for locally advanced T4 head and neck cancer. Brachytherapy 2009;8(4):385–91.Do L., Puthawala A., Syed N. et al. Interstitial brachytherapy as boost for locally advanced T4 head and neck cancer. Brachytherapy 2009;8(4):385–91.25. Pellizzon A.C., dos Santos Novaes P.E., Conte Maia M.A. et. al. Interstitial highdose-rate brachytherapy combined with cervical dissection on head and neck cancer. Head Neck 2005;27(12):1035–41.Pellizzon A.C., dos Santos Novaes P.E., Conte Maia M.A. et. al. Interstitial highdose-rate brachytherapy combined with cervical dissection on head and neck cancer. Head Neck 2005;27(12):1035–41.26. Guinot J.L., Santos M., Tortajada M.I. et al. Efficacy of high-dose-rate interstitial brachytherapy in patients with oral tongue carcinoma Brachytherapy 2010;9(3): 227–34.Guinot J.L., Santos M., Tortajada M.I. et al. Efficacy of high-dose-rate interstitial brachytherapy in patients with oral tongue carcinoma Brachytherapy 2010;9(3): 227–34.27. Patra N.B., Goswami J., Basu S. et al. Outcomes of high dose rate interstitial boost brachytherapy after external beam radiation therapy in head and neck cancer – an Indian (single institutional) learning experience. Brachytherapy 2009;8(2): 248–54.Patra N.B., Goswami J., Basu S. et al. Outcomes of high dose rate interstitial boost brachytherapy after external beam radiation therapy in head and neck cancer – an Indian (single institutional) learning experience. Brachytherapy 2009;8(2): 248–54.28. Patton B., Hu K., Perksy M., Urken M. et al. Survival and toxicity outcomes in base of tongue cancer treated with brachytherapy boost combined with 2D or IMRT: a ten year experience. Int J Radiat Oncol Biol Phys 2010;78(3):S61.Patton B., Hu K., Perksy M., Urken M. et al. Survival and toxicity outcomes in base of tongue cancer treated with brachytherapy boost combined with 2D or IMRT: a ten year experience. Int J Radiat Oncol Biol Phys 2010;78(3):S61.